Efficacy of Azole Antifungal in Treatment of Pityriasis Versicolor
DOI:
https://doi.org/10.3889/oamjms.2019.092Keywords:
Pityriasis versicolor, Malassezia, YeastAbstract
AIM: Compare itraconazole alone, fluconazole combined with ketoconazole and ketoconazole in the treatment of patients with pityriasis versicolor.
MATERIAL AND METHODS: A group of 240 pityriasis versicolor patients (confirmed with KOH and culture) were classified into 3 groups: Fluconazole 300 mg a week and 2% ketoconazole foam twice a week for 2 weeks (Category I), Itraconazole 200 mg daily for one week (category II); Ketoconazole 2% foam daily for 2 weeks (Category 3). Clinical (colour of macule, scale, pruritus) and mycological assessment were done after 4 weeks of therapy.
RESULTS: After 4 weeks of treatment, clinical cure was observed in 62.4% (Category I), 36.3% (Category II) and 37.5% (Category III).
CONCLUSION: It was reported in our study that the most effective regimen for PV patients is fluconazole 300 mg per week combined with ketoconazole 2% twice a week for 2 weeks.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Prohic A, Jovovic-Sadikovic T, Krupalija-Fazlic M, Kuskunovic-Vlahovljak S . Malassezia species in healthy skin and in dermatological conditions. Int J Dermatol. 2016; 55(5):494-504. https://doi.org/10.1111/ijd.13116 PMid:26710919 DOI: https://doi.org/10.1111/ijd.13116
Badri T, Hammami H, Bzioueche N, Zouari B, Mokhtar I. Comparative clinical trial: fluconazole alone or associated with topical ketoconazole in the treatment of pityriasisversicolor. Tunis Med. 2016;94(2):107-111. PMid:27532525
Di Fonzo EM, Martini P, Mazzatenta C, Lotti L, Alvino S. Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasisversicolor: results of a prospective, multicentre, randomised study. Mycoses. 2008; 51(6):532-535. https://doi.org/10.1111/j.1439-0507.2008.01508.x PMid:18422916 DOI: https://doi.org/10.1111/j.1439-0507.2008.01508.x
Karakas M, Durdu M, Memisoglu HR. Oral fluconazole in the treatment of tineaversicolor. J Dermatol. 2005; 32(1):19-21. https://doi.org/10.1111/j.1346-8138.2005.tb00707.x PMid:15841655 DOI: https://doi.org/10.1111/j.1346-8138.2005.tb00707.x
Kokturk A, Kaya TI, Ikizoglu G, Bugdayci R, Koca A. Efficacy of three short-term regimens of itraconazole in the treatment of pityriasisversicolor. J Dermatolog Treat. 2002; 13(4):185-187. https://doi.org/10.1080/09546630212345676 PMid:19753739 DOI: https://doi.org/10.1080/09546630212345676
Rigopoulos D, Gregoriou S, Kontochristopoulos G, Ifantides A, Katsambas A. Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasisversicolor. A randomised double-blind comparative trial. Mycoses. 2007; 50(3):193-195. https://doi.org/10.1111/j.1439-0507.2006.01352.x PMid:17472615 DOI: https://doi.org/10.1111/j.1439-0507.2006.01352.x
Cantrell WC, ElewksiBE. Can pityriasisversicolor be treated with 2% ketoconazole foam? J Drugs Dermatol. 2014; 13(7):855-859. PMid:25007370
Shi TW, Zhang JA, Tang YB, Yu HX, Li ZG, Yu JB. A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasisversicolor. J Dermatolog Treat. 2015; 26(2):143-146. https://doi.org/10.3109/09546634.2014.921661 PMid:24802530 DOI: https://doi.org/10.3109/09546634.2014.921661
Mohanty J, Sethi J, Sharma M. Efficacy of itraconazole in the treatment of tineaversicolor. Indian J Dermatol Venereol Leprol. 2001; 67(5):240-241. PMid:17664760
Kose O, BulentTastan H, RizaGur A, Kurumlu Z. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tineaversicolor. J Dermatolog Treat. 2002;13(2):77-79. https://doi.org/10.1080/095466302317584430 PMid:12060506 DOI: https://doi.org/10.1080/095466302317584430
Mohanty J, Sethi J, Sharma M. Efficacy of itraconazole in the treatment of tineaversicolor. Indian J Dermatol Venereol Leprol. 2001; 67(5):240-241. PMid:17664760
Chokoeva AA, Wollina U, Lotti T, Maximov GK, Lozev I, Tchernev G. Psoriasiform Dermatophytosis in a Bulgarian Child. Open Access Maced J Med Sci. 2018; 6(1):118-119. https://doi.org/10.3889/oamjms.2018.009 PMid:29484004 PMCid:PMC5816278 DOI: https://doi.org/10.3889/oamjms.2018.009
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Van Tran Cam, Thuong Nguyen Van, Khang Tran Hau, Doanh Le Huu, Phuong Pham Thi Minh, Sau Nguyen Huu, Thu Nguyen Minh, Marco Gandolfi, Francesca Satolli, Claudio Feliciani, Micheal Tirant, Aleksandra Vojvodic, Torello Lotti
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0